Selkirk Group Plc proposed to acquire Myprotein from THG Plc on April 23, 2025. The Board considered that the Proposal fundamentally undervalued Myprotein and its prospects, and in addition carried significant execution complexity and risks, in particular the ability of Selkirk to raise sufficient funding. On this basis, the Proposal was unequivocally rejected by the Board.

Selkirk Group cancelled the acquisition of Myprotein from THG Plc on April 23, 2025.